BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.87
Delayed Data
As of May 22
 +0.07 / +1.21%
Today’s Change
3.95
Today|||52-Week Range
7.39
+19.55%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +27.77% increase from the last price of 5.87.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$4.1M
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.62%
 
 
 
 
 
 
Growthannually -19.44%
 
 
 
 
 
 

Sales

Growthquarterly 3.39%
 
 
 
 
 
 
Growthannually -21.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.